Boston Scientific (BSX) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
- Qualcomm shares fall on Intel warning and legal concerns
- Marvell Technology shares drop on Lumentum deal concerns
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Oracle shares drop on AI spending concerns and Microsoft criticism
- SpaceX stock drops on launch setback and sector selloff
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Boston Scientific (BSX) PT Raised to $32 at Citi
February 5, 2018 6:27 AM ESTCiti raised its price target on Boston Scientific (NYSE: BSX) to $32.00 (from $31.00) while maintaining a Buy rating.
... MoreBoston Scientific (BSX) PT Raised to $35 at Needham & Company
February 1, 2018 3:28 PM ESTNeedham & Company raised its price target on Boston Scientific (NYSE: BSX) to $35.00 (from $32.00) while maintaining a Strong Buy rating.
Analyst Mike Matson commented, "BSX's 4Q17 revenue was consistent with its 1/9/18 preannouncement while its EPS met consensus. Management provided initial 2018 revenue guidance... More
Boston Scientific (BSX) PT Raised to $31 at Stifel
February 1, 2018 2:46 PM ESTStifel raised its price target on Boston Scientific (NYSE: BSX) to $31.00 (from $30.00) while maintaining a Buy rating.
... MoreBoston Scientific (BSX) PT Raised to $28.50 at Evercore ISI
February 1, 2018 12:45 PM ESTEvercore ISI raised its price target on Boston Scientific (NYSE: BSX) to $28.50 (from $27.00) while maintaining a In Line rating.
... More


